
K Patel Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 9.60 Cr
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth %
- Profit Growth -10.35%
- Ebitda -110.08%
- Net Worth 3826.62%
- Total Assets 47.03%
About K Patel Lifesciences
K Patel Lifesciences Private Limited (KPLPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 November 2020 (Four years and three months 16 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 9.60 Cr, as per Ministry of Corporate Affairs (MCA) records.
Jitendra Patel, Girish Patel, Nilesh Patel, and Three other members serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24304MH2020PTC349978
- Company No.
349978
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Nov 2020
- Date of AGM
23 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at K Patel Lifesciences?
Board Members (6)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Viraj Patel ![]() | Director | 11-Nov-2020 | Current |
Hitesh Patel ![]() | Director | 11-Nov-2020 | Current |
Jitendra Patel ![]() | Director | 11-Nov-2020 | Current |
Girish Patel ![]() | Director | 11-Nov-2020 | Current |
Nilesh Patel ![]() | Director | 11-Nov-2020 | Current |
Jugal Patel ![]() | Director | 01-Apr-2023 | Current |
Financial Performance of K Patel Lifesciences.
K Patel Lifesciences Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 10.35% decrease in profit. The company's net worth Soared by an impressive increase of 3826.62%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of K Patel Lifesciences?
In 2023, K Patel Lifesciences had a promoter holding of 99.33% and a public holding of 0.67%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- K Patel Metal Industries Private Limited
Girish Patel and Hitesh Patel are mutual person
- K Patel Dye-Chem Industries Private Limited
Jitendra Patel and Nilesh Patel are mutual person
- K Patel Chemo-Pharma Private Limited
Jitendra Patel and Nilesh Patel are mutual person
- K. Patel & Co. Private Limited
Girish Patel and Hitesh Patel are mutual person
- Ankleshwar Research And Analytical Infrastructure Association
Jitendra Patel is a mutual person
- K Patel Phyto Extractions Private Limited
Girish Patel, Hitesh Patel and 1 more are mutual person
Charges (Loans)

There are no open charges registered against the company as per our records.
How Many Employees Work at K Patel Lifesciences?
K Patel Lifesciences has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of K Patel Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped K Patel Lifesciences's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.